Factsheet on tick-borne encephalitis, for healthcare professionals
The factsheet provides concise key information on tick-borne encephalitis for medical purposes. It is appropriate for use in both endemic and non-endemic areas. (Adaptable templates available)
Leaflet on tick-borne encephalitis for the general public living in endemic areas
The leaflet provides information about ticks, the risk, the prevention of tick bites and how to react in the case of a tick bite, and sets out the symptoms for each of the potential tickborne diseases. (Adaptable templates available)
Information sheet on tick-borne encephalitis for the general public living in endemic areas
The information sheet is mainly intended for people living in endemic areas who have been bitten by (a) tick(s) so as to inform them primarily about the symptoms that they have to be aware of. (Adaptable templates available)
TBE Key risk areas: TBE average annual incidence rate per 100 000 inhabitants in the EU/EFTA at lower administrative level NUTS 2 (Italy) or NUTS 3
The key risk areas for TBE are located in central and eastern Europe and the Baltic and Nordic countries.
TBE Key risk groups: Number of TBE cases, regardless of the applied case definition, by age group and gender reported in 16 EU/EFTA countries, 2000–2010 (n= 22 378)
In Europe, TBE cases occurred more commonly among men than women and the number of reported cases increased with age.
TBE Cases by year: Number of TBE cases, regardless of the applied case definition, by year reported in 16 EU/EFTA countries, 2000–2010 (n= 29 381)
During the 2000–2010 period, the overall number of reported TBE cases (all case definitions combined) stayed relatively stable, with notable increases in 2003, 2006 and 2009–2010. The Czech Republic reported 25% of all reported cases, Lithuania 15%, Latvia and Germany 11% each and Slovenia 10%.
TBE Seasonality: Number of TBE cases, regardless of the applied case definition, by month of onset reported in nine EU/EFTA countries, 2000–2010 (n= 7 083)
The majority of cases reported during 2000–2010 showed disease onset between July and October.